Tawnya Lynn Bowles MD
Surgical Oncology (Other than Breast)
Medical Director, Melanoma Services, Intermountain Medical Center
Join to View Full Profile
5169 S Cottonwood StSte 440Murray, UT 84107
Phone+1 801-507-3915
Dr. Bowles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2008 - 2010
University of California Davis HealthResidency, Surgery, 2001 - 2008
Geisel School of Medicine at DartmouthClass of 2001
Certifications & Licensure
MT State Medical License 2025 - 2027
NV State Medical License 2024 - 2027
CA State Medical License 2003 - 2026
ID State Medical License 2025 - 2026
UT State Medical License 2010 - 2026
WY State Medical License 2025 - 2026
TX State Medical License 2008 - 2025
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow American College of Surgeons
Publications & Presentations
PubMed
- 9 citationsRP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).Michael K Wong, Mohammed M Milhem, Joseph J Sacco, Judith Michels, Gino K In
Journal of Clinical Oncology. 2025-07-08 - 11 citationsSociety of Surgical Oncology Consensus Statement: Assessing the Evidence for and Utility of Gene Expression Profiling of Primary Cutaneous Melanoma.Edmund K Bartlett, Cristina O'Donoghue, Genevieve Boland, Tawnya Bowles, Keith A Delman
Annals of Surgical Oncology. 2025-03-01 - Dramatic Responses to High-Dose Ipilimumab Plus Temozolomide After Progression on Standard- or Low-Dose Ipilimumab in Advanced Melanoma.Julie Williamson, Muhammad Zaki Hidayatullah Fadlullah, Magdalena Kovacsovics-Bankowski, Berit Gibson, Umang Swami
Current Oncology. 2025-02-28
Press Mentions
Intermountain Health Launches Cancer Treatment Program for Patients with Advanced Melanoma Skin CancerJune 6th, 2025- 10 Ways to Prevent Skin Cancer This SummerJuly 12th, 2021
Polynoma Presenting Interim Phase III Data for Its Investigational Melanoma Vaccine, Seviprotimut-L, at the 2019 Society for Immunotherapy of Cancer (SITC) Annual MeetingDecember 3rd, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
